Patients acting as consumers, as observed in the AOM launches, increasingly influence prescriber choices
There were no significant differences in glimepiride pharmacokinetics between the two age groups (see CLINICALPHARMACOLOGY, SpecialPopulations, Geriatric)
Semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) while tirzepatide injection is $289/mo month-to-month, or from $249/mo on the 6-month plan, both with flat monthly pricing regardless of dose
Through compounded telehealth providers with transparent pricing, annual costs typically range from $1,800$4,800
MiraLAX, being tasteless, is often easy to incorporate into daily routines
This remarkable affordability is a direct result of aggressive competition, primarily from Eli Lilly's Zepbound